Advertisement
Satsuma Pharmaceuticals I... (STSA)
NASDAQ: STSA
· Real-Time Price · USD
1.10
0.00 (0.00%)
At close: Jun 07, 2023, 8:00 PM
0.00% (1D)
| Bid | n/a |
| Market Cap | 36.47M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -63.33M |
| EPS (ttm) | -1.99 |
| PE Ratio (ttm) | -0.5527638190954773 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 1,826,389 |
| Avg. Volume (20D) | 1,106,610 |
| Open | 1.11 |
| Previous Close | 1.10 |
| Day's Range | 1.10 - 1.10 |
| 52-Week Range | 0.59 - 8.08 |
| Beta | 0.10 |
About STSA
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharma...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 13, 2019
Employees 25
Stock Exchange NASDAQ
Ticker Symbol STSA
Website https://www.satsumarx.com